However, if tumor cells express the co-inhibitory molecule PD-L1, PD-1 on T cells bind to PD-L1 of tumor cells and the cytotoxicity of CD8+ T cells will be reduced (Figure 1A). The gene discussed is CD8A; the disease is neoplasm.